Investigational Drug Information for DWP16001
✉ Email this page to a colleague
What is the development status for investigational drug DWP16001?
DWP16001 is an investigational drug.
There have been 21 clinical trials for DWP16001.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 14th 2020.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Metabolic Diseases. The leading clinical trial sponsors are Daewoong Pharmaceutical Co. LTD. and [disabled in preview].
Summary for DWP16001
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2020-12-14) |
| Vendors | 15 |
Recent Clinical Trials for DWP16001
| Title | Sponsor | Phase |
|---|---|---|
| To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
Clinical Trial Summary for DWP16001
Top disease conditions for DWP16001
Top clinical trial sponsors for DWP16001
US Patents for DWP16001
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
